{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T13:30:32Z","timestamp":1777555832219,"version":"3.51.4"},"reference-count":27,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2008,10,1]],"date-time":"2008-10-01T00:00:00Z","timestamp":1222819200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2008,10]]},"DOI":"10.1016\/j.neuropharm.2008.05.032","type":"journal-article","created":{"date-parts":[[2008,6,6]],"date-time":"2008-06-06T08:12:59Z","timestamp":1212739979000},"page":"654-660","source":"Crossref","is-referenced-by-count":17,"title":["A neuroprotective agent, T-817MA (1-{3-[2-(1-benzothiophen-5-yl)ethoxy]propyl} azetidin-3-ol maleate), prevents 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity in mice"],"prefix":"10.1016","volume":"55","author":[{"given":"Toshiyuki","family":"Kawasaki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukio","family":"Ago","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatsuya","family":"Kitao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsuaki","family":"Nashida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akiko","family":"Takagi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuhiro","family":"Takuma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshio","family":"Matsuda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2008.05.032_bib1","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/0304-3940(94)90684-X","article-title":"Immunocytochemical analysis of tumor necrosis factor and its receptors in Parkinson's disease","volume":"172","author":"Boka","year":"1994","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2008.05.032_bib2","doi-asserted-by":"crossref","first-page":"14669","DOI":"10.1073\/pnas.251341998","article-title":"Minocycline prevents nigrostriatal dopaminergic neurodegeneration in the MPTP model of Parkinson's disease","volume":"98","author":"Du","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"10.1016\/j.neuropharm.2008.05.032_bib3","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.neuint.2005.08.012","article-title":"T-817MA, a novel neurotrophic agent, improves sodium nitroprusside-induced mitochondrial dysfunction in cortical neurons","volume":"48","author":"Fukushima","year":"2006","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.neuropharm.2008.05.032_bib4","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1046\/j.1471-4159.2002.00928.x","article-title":"Microglial activation-mediated delayed and progressive degeneration of rat nigral dopaminergic neurons: relevance to Parkinson's disease","volume":"81","author":"Gao","year":"2002","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuropharm.2008.05.032_bib5","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1523\/JNEUROSCI.23-04-01228.2003","article-title":"Critical role of microglia NADPH oxidase-derived free radicals in the MPTP model of Parkinson's disease","volume":"23","author":"Gao","year":"2003","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2008.05.032_bib6","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1111\/j.1471-4159.2006.03907.x","article-title":"Oxidative stress and neurodegeneration: where are we now?","volume":"97","author":"Halliwell","year":"2006","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuropharm.2008.05.032_bib7","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1124\/jpet.105.083543","article-title":"A novel neurotrophic agent, T-817MA (1-{3-[2-(1-benzothiophen-5-yl)ethoxy]propyl}-3-azetidinol maleate), attenuates amyloid-\u03b2-induced neurotoxicity and promotes neurite outgrowth in rat cultured central nervous system neurons","volume":"314","author":"Hirata","year":"2005","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2008.05.032_bib8","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.brainres.2004.09.046","article-title":"Arundic acid, an astrocyte-modulating agent, protects dopaminergic neurons against MPTP neurotoxicity in mice","volume":"1030","author":"Kato","year":"2004","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2008.05.032_bib9","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.ejphar.2006.05.012","article-title":"Protective effect of the radical scavenger edaravone against methamphetamine-induced dopaminergic neurotoxicity in mouse striatum","volume":"542","author":"Kawasaki","year":"2006","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2008.05.032_bib10","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1124\/jpet.106.119206","article-title":"Edaravone (3-methyl-1-phenyl-2-pyrazolin-5-one), a radical scavenger, prevents 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity in the substantia nigra but not the striatum","volume":"322","author":"Kawasaki","year":"2007","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2008.05.032_bib11","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1038\/70978","article-title":"Inducible nitric oxide synthase stimulates dopaminergic neurodegeneration in the MPTP model of Parkinson disease","volume":"5","author":"Liberatore","year":"1999","journal-title":"Nat. Med."},{"key":"10.1016\/j.neuropharm.2008.05.032_bib12","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.bbadis.2003.09.007","article-title":"Endomorphins, endogenous opioid peptides, provide antioxidant defense in the brain against free radical-induced damage","volume":"1639","author":"Lin","year":"2003","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.neuropharm.2008.05.032_bib13","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1002\/ana.10728","article-title":"Presence of reactive microglia in monkey nigra years after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine administration","volume":"54","author":"McGeer","year":"2003","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neuropharm.2008.05.032_bib14","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/0304-3940(96)12706-3","article-title":"Interleukin (IL)-1\u03b2, IL-2, IL-4, IL-6 and transforming growth factor-\u03b1 levels are elevated in ventricular cerebrospinal fluid in juvenile parkinsonism and Parkinson's disease","volume":"211","author":"Mogi","year":"1996","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2008.05.032_bib15","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/0304-3940(94)90746-3","article-title":"Tumor necrosis factor-\u03b1 (TNF-\u03b1) increases both in the brain and in the cerebrospinal fluid from Parkinsonian patients","volume":"65","author":"Mogi","year":"1994","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2008.05.032_bib16","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1146\/annurev.neuro.28.061604.135718","article-title":"Molecular pathophysiology of Parkinson's disease","volume":"28","author":"Moore","year":"2005","journal-title":"Annu. Rev. Neurosci."},{"key":"10.1016\/j.neuropharm.2008.05.032_bib17","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1002\/hipo.20281","article-title":"Ameliorative effects of a neuroprotective agent, T-817MA, on place learning deficits induced by continuous infusion of amyloid-\u03b2 peptide (1\u201340) in rats","volume":"17","author":"Nguyen","year":"2007","journal-title":"Hippocampus"},{"key":"10.1016\/j.neuropharm.2008.05.032_bib18","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1179\/135100002125000587","article-title":"Edarabone scavenges nitric oxide","volume":"7","author":"Satoh","year":"2002","journal-title":"Redox Rep."},{"key":"10.1016\/j.neuropharm.2008.05.032_bib19","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1111\/j.1471-4159.1990.tb02325.x","article-title":"Mitochondrial complex I deficiency in Parkinson's disease","volume":"54","author":"Schapira","year":"1990","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuropharm.2008.05.032_bib20","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0166-4328(01)00309-6","article-title":"Behavioral phenotyping of the MPTP mouse model of Parkinson's disease","volume":"125","author":"Sedelis","year":"2001","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuropharm.2008.05.032_bib21","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1111\/j.1471-4159.2005.03566.x","article-title":"Minocycline attenuates microglial activation but fails to mitigate striatal dopaminergic neurotoxicity: role of tumor necrosis factor-\u03b1","volume":"96","author":"Sriram","year":"2006","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuropharm.2008.05.032_bib22","doi-asserted-by":"crossref","first-page":"5473","DOI":"10.1073\/pnas.0837397100","article-title":"Cyclooxygenase-2 is instrumental in Parkinson's disease neurodegeneration","volume":"100","author":"Teismann","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"10.1016\/j.neuropharm.2008.05.032_bib23","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1080\/1521654032000114320","article-title":"Nitric oxide and reactive oxygen species in Parkinson's disease","volume":"55","author":"Tieu","year":"2003","journal-title":"IUBMB Life"},{"key":"10.1016\/j.neuropharm.2008.05.032_bib24","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1038\/sj.bjp.0707167","article-title":"Inflammation as a causative factor in the aethiology of Parkinson's disease","volume":"150","author":"Whitton","year":"2007","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2008.05.032_bib25","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1523\/JNEUROSCI.22-05-01763.2002","article-title":"Blockade of microglial activation is neuroprotective in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson disease","volume":"22","author":"Wu","year":"2002","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2008.05.032_bib26","doi-asserted-by":"crossref","first-page":"6145","DOI":"10.1073\/pnas.0937239100","article-title":"NADPH oxidase mediates oxidative stress in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease","volume":"100","author":"Wu","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"10.1016\/j.neuropharm.2008.05.032_bib27","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1002\/jnr.10709","article-title":"Minocycline enhances MPTP toxicity to dopaminergic neurons","volume":"74","author":"Yang","year":"2003","journal-title":"J. Neurosci. Res."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390808001676?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390808001676?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,12]],"date-time":"2019-05-12T00:14:36Z","timestamp":1557620076000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390808001676"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,10]]},"references-count":27,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2008,10]]}},"alternative-id":["S0028390808001676"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2008.05.032","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2008,10]]}}}